Nikmox BR Eye Drops are a pharmaceutical solution combining Bromfenac (0.09% w/v) and Moxifloxacin (0.5% w/v). Indicated for the treatment of inflammation and pain associated with ocular anterior segment diseases, including post-operative inflammation and persistent corneal epithelial defects. Bromfenac, a non-steroidal anti-inflammatory drug (NSAID), reduces inflammation and pain, while Moxifloxacin, a quinolone antibiotic, provides broad-spectrum antibacterial activity. Nikmox BR Eye Drops should be used with caution in patients with known hypersensitivity to quinolones or bromfenac, and under the guidance of a healthcare professional. Common adverse effects may include eye irritation, burning, and stinging upon instillation. Proper storage and administration instructions should be followed to ensure product efficacy and patient safety.